Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine

To re-analyse the clinical outcomes and interferon (IFN) activity data from the JOQUER trial, a phase III trial investigating hydroxychloroquine (HCQ) in patients with primary Sjögren’s syndrome (pSS), after stratifying patients into putative pathobiological subgroups utilizing the Newcastle Sjögren...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Alexis, Lendrem, Dennis, Wason, James, Tarn, Jessica, Howard-Tripp, Nadia, Bodewes, Iris, Versnel, Marjan A., Gottenberg, Jacques-Eric, Seror, Raphaele, Mariette, Xavier, Ng, Wan-Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316226/
https://www.ncbi.nlm.nih.gov/pubmed/34165604
http://dx.doi.org/10.1007/s00296-021-04927-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316226/
https://www.ncbi.nlm.nih.gov/pubmed/34165604
http://dx.doi.org/10.1007/s00296-021-04927-y

Ejemplares similares